STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
226.87
+0.38 (0.17%)
Aug 1, 2025, 4:00 PM - Market closed
Activision Blizzard Revenue
In the fiscal year ending March 31, 2025, STERIS had annual revenue of $5.46B with 6.24% growth. STERIS had revenue of $1.48B in the quarter ending March 31, 2025, with 4.31% growth.
Revenue (ttm)
$5.46B
Revenue Growth
+6.24%
P/S Ratio
4.10
Revenue / Employee
$306,938
Employees
17,787
Market Cap
22.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.46B | 320.81M | 6.24% |
| Mar 31, 2024 | 5.14B | 602.44M | 13.28% |
| Mar 31, 2023 | 4.54B | 312.86M | 7.41% |
| Mar 31, 2022 | 4.22B | 1.12B | 35.91% |
| Mar 31, 2021 | 3.11B | 76.62M | 2.53% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
STE News
- 3 days ago - STERIS Raises Dividend to $0.63 per share - GlobeNewsWire
- 11 days ago - STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025 - GlobeNewsWire
- 2 months ago - U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report 2025-2030 Featuring STERIS, The Brewer Company, Midmark Corp. (Ritter Midmark), Clinton Industries, UMF Medical and More - GlobeNewsWire
- 2 months ago - Steris: May Benefit From Bringing Pharmaceutical Manufacturing Back To The U.S. - Seeking Alpha
- 2 months ago - STERIS plc (STE) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Why This Medical Equipment Stock Is Today's S&P 500 Winner - Barrons
- 2 months ago - Steris forecasts annual profit above estimates on strong medical equipment sales - Reuters
- 2 months ago - Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers - Investopedia